Department of Ophthalmology and Visual Science, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Department of Innovative Visual Science, Osaka University Medical School, Suita, Osaka, Japan.
Sci Rep. 2017 Jul 20;7(1):5973. doi: 10.1038/s41598-017-06344-3.
Corneal transplantation is a safe, reliable method of restoring visual acuity in patients with corneal disorders. Although it has a very high success rate, rejection can still occur, especially if the site is infected. Therefore, seeking to find better ways to manage infection risk, this study investigated a new technique, based on multiplex polymerase chain reaction (mPCR), to identify pathogens, including viruses, bacteria, and fungi, in corneal transplantation recipient sites, donor corneas and the donor cornea storage solution. The subjects comprised 50 patients who underwent corneal transplantation at Tohoku University Hospital between July 2014 and April 2015. We obtained extracted (recipient) cornea samples in 37 cases, donor cornea samples in 50 cases, and corneal storage solution samples in 50 cases (18 of these 50 samples contained DNA). Herpes simplex virus type 1 DNA was detected in four recipient corneas, Parvovirus B19 DNA was detected in two recipient corneas, Human herpes virus type 6 was detected in two donor corneas, and Aspergillus DNA was detected in one corneal storage solution sample. Thus, mPCR successfully identified pathogenic DNA in corneal tissues and storage solution, suggesting that evaluation with mPCR may improve the ability to predict the risk of infection after corneal transplantation.
角膜移植是一种安全、可靠的方法,可恢复角膜疾病患者的视力。尽管它的成功率非常高,但仍然可能发生排斥反应,特别是如果部位感染。因此,为了寻求更好的方法来管理感染风险,本研究调查了一种新的技术,基于多重聚合酶链反应(mPCR),以鉴定角膜移植受者部位、供体角膜和供体角膜储存液中的病原体,包括病毒、细菌和真菌。研究对象包括 2014 年 7 月至 2015 年 4 月在东北大学医院接受角膜移植的 50 名患者。我们获得了 37 例受者角膜样本、50 例供体角膜样本和 50 例角膜储存液样本(其中 18 例样本含有 DNA)。在 4 例受者角膜中检测到单纯疱疹病毒 1 型 DNA,在 2 例受者角膜中检测到微小病毒 B19 DNA,在 2 例供体角膜中检测到人类疱疹病毒 6 型,在 1 例角膜储存液样本中检测到曲霉属 DNA。因此,mPCR 成功地鉴定了角膜组织和储存液中的致病 DNA,表明 mPCR 的评估可能提高预测角膜移植后感染风险的能力。